SA PRO
Free Account
MannKind CorporationMNKDNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
17 analysts·Moderate coverage
47%
Rating Distribution
Strong Buy
00%
Buy
847%
Hold
212%
Sell
741%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 24, 2025Truist Financial
MannKind initiated with a Buy at Truist
Target:$9.00
+78.9%from $5.03
Sep 2, 2025H.C. Wainwright
MannKind price target raised to $11 from $9 at H.C. Wainwright
Target:$11.00
+91.6%from $5.74
Aug 26, 2025RBC Capital
MannKind price target raised to $8 from $7 at RBC Capital
Target:$8.00
+100.0%from $4.00
Aug 25, 2025H.C. Wainwright
H.C. Wainwright positive on MannKind deal for scPharmaceuticals
Target:$9.00
+130.8%from $3.90
Aug 28, 2024Oppenheimer
MannKind price target raised to $12 from $10 at Oppenheimer
Target:$12.00
+123.0%from $5.38
Oct 10, 2023Wedbush
MannKind Analyst Turns Bullish, Says 'Don't Call It Comeback'
Target:$10.00
+136.4%from $4.23

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance